Atara Biotherapeutics (ATRA) vs Conexeu Sciences (CNXU)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Conexeu Sciences is the larger company by market cap ($97.3 million vs $92.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ATRA | CNXU |
|---|---|---|
| Share price | $9.23 | $3.45 |
| Market cap | $92.65M | $97.31M |
| 1-day change | -1.49% | -5.22% |
| YTD return | -48.98% | — |
| 1-year return | -41.77% | — |
| 5-year return | -97.56% | — |
| Forward P/E | 5.97 | — |
| EPS (TTM) | $-1.26 | $-0.58 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.15 | $18.79 |
| 52-week low | $3.92 | $3.05 |
| Distance from 52-week high | -51.79% | -81.64% |
| Analyst consensus | buy | none |
| Avg. price target upside | +48.10% | +479.71% |
| Average volume | 53.79K | 203.38K |
| Shares outstanding | 10.04M | 28.21M |
| Employees | 10 | — |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Atara Biotherapeutics
ATRA stock →Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and internationally.
Healthcare · Biotechnology · 10 employees
About Conexeu Sciences
CNXU stock →Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair.
Healthcare · Biotechnology
ATRA vs CNXU FAQ
Which is bigger, Atara Biotherapeutics or Conexeu Sciences?
Conexeu Sciences (CNXU) is larger, with a market capitalization of $97.31M compared with $92.65M for Atara Biotherapeutics (ATRA).
Are Atara Biotherapeutics and Conexeu Sciences in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.